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The carbohydrate pitopes L2/HNK-1 and L3 have previously been identified on various neural cell adhesion molecules 
and have been suggested to play a role in the mediation of cell-cell adhesion. In this study, the developmental expression 
of the two epitopes in soluble, membrane-bound and chloroform/methanol-extracted fractions of the constituent mouse 
brain regions was examined by enzyme-linked immunosorbent assay (ELISA). The protein-bound epitopes were shown 
to be uniformly developmentally regulated, with levels peaking at postnatal day 20 (P20). The epitopes in a crude chloro- 
form/methanol fraction, however, demonstrated a different pattern, with L2 peaking earlier at postnatal day zero (PO). 
These results suggest a possible interaction between the control of the two pools of the epitope. 
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1. INTRODUCTION 
Nervous tissue contains a large number of lipid- 
and protein-bound carbohydrate groups which 
play a major role in both its structuring and func- 
tioning. One such carbohydrate group is the 
sulfated N-linked oligosaccharide LZ/HNK-1 
epitope [l] which is present on both the neural cell 
adhesion molecule (N-CAM) and other CNS 
polypeptides including Ll , myelin-associated 
glycoprotein (MAG), PO, integrin and the adhesion 
molecule on glia (AMOG) [2-71 as well as being on 
glycolipids [8]. The epitope itself, a sulfated 
glucuronic acid derivative [9,10], has been pro- 
posed to mediate cell-cell interaction [ 1 l-l 31. A 
second carbohydrate epitope, L3, has been iden- 
tified and is also present on various CAMS in- 
cluding N-CAM, AMOG, integrin and PO [2,7,14]. 
The expression of L2 has been demonstrated to 
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regulate developmentally with respect to both its 
total and specific polypeptide expression [1% 181. 
Hence, the developmental expression of protein- 
and lipid-bound L2 and L3 epitopes was examined 
in developing mouse brain. 
2. MATERIALS AND METHODS 
2.1. Brain fractionation 
Mice (NMRI strain) of differing developmental ages were 
killed by decapitation. The brains were dissected and 
homogenised in ice-cold 20 mM Tris-HCl @H 7.2) containing 
150 mM NaCl, 1 mM EDTA and 1 mM EGTA. All solutions 
used contained protease inhibitors. The homogenate was cen- 
trifuged at 100000 x g for 1 h at 4’C resulting in a membrane 
pellet and a supernatant fraction. A crude lipid extract of the 
pellet was then prepared. The pellet was resuspended in 1 ml 
chloroform/methanol (2: I), vortex-mixed, and the protein 
pelleted in a microfuge. Following extraction, the solvent was 
evaporated and the lipid content resuspended in 1 ml water. 
The post-extraction protein-containing pellet was also 
resuspended in 1 ml water by sonication, and all fractions 
stored at -70°C until use. The protein content of the soluble 
and pellet fractions was determined [19] using bovine serum 
albumin (BSA) as a protein standard. 
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2.2. Carbohydrate pitope determination 
The concentrations of L2 and L3 in the three brain fractions 
was determined by ELISA. The brain fractions (up to 1 pg pro- 
tein in 0.1 M NaHCOs) were attached to a solid-phase !&well 
polystyrene microtiter plate. The wells were blocked for 1 h 
with 1% BSA in 0.1 M NaHCOr and then washed three times 
in calcium- and magnesium-free phosphate-buffered saline 
(CMF-PBS) containing 0.5% Tween 20 (wash buffer). These 
were incubated with 1OOpl of the respective monoclonal an- 
tibodies [l : 50 dilution with CMF-PBS containing 0.5% Tween 
20 and 1% BSA (dilution buffer)] against L2 and L3 [4,14] for 
2 h at room temperature. The plates were then rinsed three 
times with wash buffer and the wells incubated with lOO/cl of 
a peroxidase-conjugated goat anti-rat antibody (1:50 with 
diluting buffer) for 2 h and subsequently washed three times as 
before. The amount of bound immunoglobulin was visualised 
by the addition of 100~1 acetate buffer, pH 4.2, containing 
chromogenic substrate, 2,2’-axinodi-3-ethylbenxthiaxolinesul- 
fonate [6] (ABTS), and hydrogen peroxide (0.28pl/ml). The 
reaction was stopped after 5 min by the addition of 50~1 of 
0.6% SDS. The absorbance was then measured at 405 nm. 
Samples which had been incubated with the goat anti-rat im- 
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Fig.1. Developmental regulation of the L2 and L3 epitopes in (a) membrane, (b) soluble and (c) chloroform/methanol fractions 
obtained from developing mouse brain. Points represent mean f SE (n = 3) and are expressed as absorbance units (&s) per mg protein 
(soluble and membrane-bound fractions) and absorbance units (&OS) per g wet wt (chloroform/methanol extract). 
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Fig.2. Regional developmental expression of L2 and L3 in constituent brain regions. Points represent mean (n = 3) and are expressed 
as in fig.1. Brain regions indicated: C, cortex; Cb, cerebellum; T, thalamus; M, midbrain; Sp, spinal cord; S, striatum; K 
hypothalamus; B, brain stem. 
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munoglobulin antibody only served as a measure of non- 
specific antibody binding. The assay was characterised with 
respect o the linearity of both antigen detection and lipid/pro- 
tein binding to the wells. All detections were carried out within 
the linear range of both variables. The antigen content was ex- 
pressed as absorbance units (&s) per mg protein for the solu- 
ble and pellet fractions and Aa5 per g brain wet wt for the 
chloroform/methanol fraction. Although expressed in 
reference to total brain wet wt. there was a direct correlation 
between brain protein and wet wt in the samples used allowing 
for a comparison of the epitope levels in the three fractions. 
3. RESULTS AND DISCUSSION 
In both membrane-bound and soluble protein 
fractions, there was a developmental increase in 
expression of both L2 and L3 epitopes coincident 
with age up to a peak of expression at postnatal 
day 20. This was followed by a subsequent 
decrease to adult expression levels (fig. la,b). These 
results are in good agreement with those published 
previously for protein-bound L2 [18]. Further in- 
vestigation into the developmental regulation of 
protein-bound sugars in the different brain regions 
indicated that this followed the same general pat- 
tern and was not region-specific (fig.2). A peak 
enrichment of the two epitopes was seen in the 
hypothalamic, brainstem, spinal cord and mid- 
brain regions at postnatal day 20. 
A different developmental pattern was seen, 
however, for the epitopes in the chloroform/ 
methanol fraction (fig.lc). While this crude frac- 
tion contains mainly lipid-bound sugars, one 
cannot rule out the possibility of some small 
proteoglycans also being present. The developmen- 
tal pattern of L2 in this fraction is, however, in 
good agreement with previous studies on lipid- 
bound L2 in rat brain [18], indicating that the 
epitope detected in this fraction is probably lipid- 
bound. Both in total brain and in the constituent 
regions, L2 expression peaked at postnatal day 
zero, followed by a decrease to adult levels. This is 
in contrast with protein-bound L2 which peaked 
later at postnatal day 20, thereafter decreasing to 
adult. No clear overall pattern was seen with L3 
levels. In total brain, there was only a slight in- 
crease in expression of L3 from postnatal days 0 to 
20. At a regional level, however, there was a con- 
siderable variation in developmental expression 
with some regions registering an increase, while 
others registered a decrease in expression. It is like- 
ly, therefore, that these regional variations 
counteract each other to result in the slight increase 
seen for total brain. Both epitopes in this fraction 
displayed a regional enrichment similar to that 
seen in the membrane-bound and soluble protein 
fractions (fig.2). 
Recent studies have been performed on the con- 
trol of the ~(2-8) polysialic acid chain on N-CAM. 
These have suggested that this chain is transferred 
to the polypeptide in total, rather than as in- 
dividual sialic acid units [20,21] as has previously 
been described for certain bacterial systems 
[22,23]. This process is suggested to occur via a 
membrane lipid intermediate, on which the chain is 
synthesised and elongated prior to transfer. With 
L2, we have seen a sequential developmental ex- 
pression of the sugar in lipid, followed by protein 
fractions. Furthermore, there is also a good 
regional agreement between epitope levels in the 
lipid and protein fractions. It is therefore tempting 
to speculate that the L2 epitope may be synthesised 
in total on a lipid intermediate, before being 
transferred to the final glycoprotein acceptor 
where it plays its functional role. 
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